Summary of Significant Accounting Policies (Tables)

9 Months Ended

Sep. 30, 2022

Accounting Policies [Abstract]

Schedule of Cash and Cash Equivalents

The following table provides a reconciliation of cash, cash equivalents and restricted cash within the condensed consolidated balance sheets that sum to the total of the same on the condensed consolidated statement of cash flows (in thousands):

	September 30, 2022		December 31, 2021
Cash and cash equivalents	$	201,221	$	374,294
Restricted cash	6,131		5,112
Total cash, cash equivalents and restricted cash	$	207,352	$	379,406

Schedule of Earnings Per Share, Basic and Diluted

The following table presents the calculation of basic and diluted net loss per share (in thousands, except shares and per share data):

	Three Months Ended September 30,				Nine Months Ended September 30,
	2022		2021		2022		2021
Basic loss per share:
Net loss	$	(152,746)	$	(105,865)	$	(409,837)	$	(270,981)
Less: net loss attributable to non-controlling interest	98		14		341		105
Net loss attributable to common stockholders	$	(152,648)	$	(105,851)	$	(409,496)	$	(270,876)
Shares used in computation:
Weighted-average common shares outstanding	186,750,504		142,529,770		176,503,992		133,941,485
Basic and diluted loss per share	$	(0.82)	$	(0.74)	$	(2.32)	$	(2.02)

Schedule of Antidilutive Securities Excluded from Computation of Earnings per Share

The following common share equivalents are excluded from the calculation of weighted average common shares outstanding because their inclusion would have been anti-dilutive:

	September 30,
	2022	2021
Warrants to purchase common stock	166,670	893,266
Stock options	15,655,673	16,131,605
Unvested restricted stock units	6,859,083	1,331,380
Convertible notes variable settlement feature	6,966,078	6,966,078
Total	29,647,504	25,322,329

Accounting Standards Update and Change in Accounting Principle

The following table summarizes the adjustments made to the Company’s condensed consolidated balance sheet as of January 1, 2022 as a result of applying the modified retrospective method in adopting ASU 2020-06 (in thousands):

	As Reported December 31, 2021		ASU 2020-06 Adjustments		As Adjusted January 1, 2022
2026 Convertible Notes	$	316,354	$	75,264	$	391,618
Additional paid-in capital	$	1,691,206	$	(87,946)	$	1,603,260
Accumulated deficit	$	(1,009,293)	$	12,682	$	(996,611)

Restrictions on Cash and Cash Equivalents

The following table provides a reconciliation of cash, cash equivalents and restricted cash within the condensed consolidated balance sheets that sum to the total of the same on the condensed consolidated statement of cash flows (in thousands):

	September 30, 2022		December 31, 2021
Cash and cash equivalents	$	201,221	$	374,294
Restricted cash	6,131		5,112
Total cash, cash equivalents and restricted cash	$	207,352	$	379,406